A common point of opposition to offering buprenorphine in correctional settings is the perceived risk of diversion, disciplinary issues, or safety concerns created by allowing access to buprenorphine.
Vital Strategies supported technical assistance to six county jails in Pennsylvania that had been funded by the Commonwealth to expand access to buprenorphine to incarcerated persons.
This snapshot looks at the reported incidence of diversion, assault, and conduct citations at the six jails in Pennsylvania that together provided buprenorphine to more than 1,000 individuals over an 18 month period through this state-funded grant program.
Recent Abstracts
The Power of Storytelling: Guidance for the Creation of Testimonials
Lead Poisoning and Early Childhood Development
Prioritizing Evidence Gaps: Air Pollution and Health Impacts of Climate Action
Raising Alcohol Taxes to Reduce Harm: Fact Sheets for Brazil
Risk of mortality by aggression: A retrospective cohort study in women with notification…
How the Alcohol Industry Steers Governments Away From Effective Strategies to Curb Drink…
Analysis of the Efficacy of Alcohol Industry-Sponsored Drink-Driving Campaigns
Messaging Recommendations for Effective Road Safety Campaigns: Lessons From Formative Research for Drink…
Prescribing Psychostimulants for the Treatment of Stimulant Use Disorder: Navigating the Federal Legal…
Enforcement of COTPA in India- current status, challenges and solutions